Cancer Institute NSW on X: "Two new calculators are available to support the #eviQ ADDIKD guideline. Get started with the Carboplatin Dose calculator: https://t.co/vJePzryZXF https://t.co/cgKpCpMS3j" / X
![PDF] Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level. | Semantic Scholar PDF] Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/04a3d4ce989f432a02924f0cc761c89871af398d/4-Table2-1.png)
PDF] Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level. | Semantic Scholar
![Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) | Breast Cancer Research and Treatment Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) | Breast Cancer Research and Treatment](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10549-020-05868-z/MediaObjects/10549_2020_5868_Fig1_HTML.png)
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) | Breast Cancer Research and Treatment
![Carboplatin dose calculations for patients with lung cancer: significant dose differences found depending on dosing equation choice | BMC Cancer | Full Text Carboplatin dose calculations for patients with lung cancer: significant dose differences found depending on dosing equation choice | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-022-09885-7/MediaObjects/12885_2022_9885_Fig7_HTML.png)
Carboplatin dose calculations for patients with lung cancer: significant dose differences found depending on dosing equation choice | BMC Cancer | Full Text
![Overestimation of carboplatin doses is avoided by radionuclide GFR measurement | British Journal of Cancer Overestimation of carboplatin doses is avoided by radionuclide GFR measurement | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2012.393/MediaObjects/41416_2012_Article_BFbjc2012393_Fig1_HTML.jpg)